Women are and will be the predominant users of GLP-1 users, but research gaps remain critical

The 2nd of a Series of papers presented astatine the Annual Meeting of The European Association for the Study of Diabetes (EASD) successful Milan, Italy (Sept 28—Oct 2) and published successful The Lancet Obstetrics, Gynaecology & Women's Health discusses the wide-ranging issues relating to usage of GLP-1 RA cause usage successful women. The authors, that see Professor Paul Franks, Lund University, Helsingborg Hospital, Helsingborg, Sweden and Professor Claire Meek, Leicester Diabetes Research Centre and Leicester NIHR Biomedical Research Centre, Leicester, UK and colleagues, contented a telephone to enactment to amended the grounds based crossed the committee for GLP-1 RA usage successful women worldwide.